Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes

Patients with cancer who develop breakthrough infection following COVID-19 vaccination remain at risk for severe outcomes, according to a study published online Dec. 24 in theĀ Annals of Oncology. Andrew L. Schmidt, M.B., B.S., from the Dana-Farber Cancer Institute in Boston, and colleagues examined the clinical features of patients with cancer who developed symptomatic COVID-19 following … Continue reading Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes